RSV vaccine costs raise concerns
As the rollout of the Respiratory Syncytial Virus (RSV) vaccine gains momentum, concerns are emerging regarding accessibility and potential costs for vulnerable populations.
As the rollout of the Respiratory Syncytial Virus (RSV) vaccine gains momentum, concerns are emerging regarding accessibility and potential costs for vulnerable populations.